Cargando…

In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy

SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment that uses photoreactive agents and light irradiation, while photodynamic therapy (PDT) is an existing phototherapy using photosensitizers and light irradiation as well as NIR-PIT. The current study inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Susumu, Kojima, Miho, Onda, Nobuhiko, Shibutani, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340659/
https://www.ncbi.nlm.nih.gov/pubmed/37444510
http://dx.doi.org/10.3390/cancers15133400
_version_ 1785072132247519232
author Yamashita, Susumu
Kojima, Miho
Onda, Nobuhiko
Shibutani, Makoto
author_facet Yamashita, Susumu
Kojima, Miho
Onda, Nobuhiko
Shibutani, Makoto
author_sort Yamashita, Susumu
collection PubMed
description SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment that uses photoreactive agents and light irradiation, while photodynamic therapy (PDT) is an existing phototherapy using photosensitizers and light irradiation as well as NIR-PIT. The current study investigated the properties of these therapies and their differences with a focus on their cellular binding/uptake specificity and cytotoxicity in vitro. NIR-PIT showed molecule-selective responses and cytotoxicity, whereas PDT showed non-selective cell type responses and cytotoxicity. Additionally, NIR-PIT and PDT induced damage-associated molecular patterns (DAMPs), a surrogate marker of immunogenic cell death, although PDT had different sensitivity between cell lines. Therefore, molecule-specific NIR-PIT may have advantages compared with PDT in terms of efficiency in tumor visualization and induction of DAMPs. ABSTRACT: Near-infrared photoimmunotherapy (NIR-PIT) is a new phototherapy that utilizes a monoclonal antibody (mAb) against cancer antigens and a phthalocyanine dye, IRDye700DX (IR700) conjugate (mAb-IR700). Photodynamic therapy (PDT) is a combination therapy that utilizes photoreactive agents and light irradiation as well as NIR-PIT. In the present study, we compared these therapies in vitro. The characterization of cellular binding/uptake specificity and cytotoxicity were examined using two mAb-IR700 forms and a conventional PDT agent, talaporfin sodium, in three cell lines. As designed, mAb-IR700 had high molecular selectivity and visualized target molecule-positive cells at the lowest concentration examined. NIR-PIT induced necrosis and damage-associated molecular patterns (DAMPs), a surrogate maker of immunogenic cell death. In contrast, talaporfin sodium was taken up by cells regardless of cell type, and its uptake was enhanced in a concentration-dependent manner. PDT induced cell death, with the pattern of cell death shifting from apoptosis to necrosis depending on the concentration of the photosensitizer. Induction of DAMPs was observed at the highest concentration, but their sensitivity differed among cell lines. Overall, our data suggest that molecule-specific NIR-PIT may have potential advantages compared with PDT in terms of the efficiency of tumor visualization and induction of DAMPs.
format Online
Article
Text
id pubmed-10340659
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103406592023-07-14 In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy Yamashita, Susumu Kojima, Miho Onda, Nobuhiko Shibutani, Makoto Cancers (Basel) Article SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment that uses photoreactive agents and light irradiation, while photodynamic therapy (PDT) is an existing phototherapy using photosensitizers and light irradiation as well as NIR-PIT. The current study investigated the properties of these therapies and their differences with a focus on their cellular binding/uptake specificity and cytotoxicity in vitro. NIR-PIT showed molecule-selective responses and cytotoxicity, whereas PDT showed non-selective cell type responses and cytotoxicity. Additionally, NIR-PIT and PDT induced damage-associated molecular patterns (DAMPs), a surrogate marker of immunogenic cell death, although PDT had different sensitivity between cell lines. Therefore, molecule-specific NIR-PIT may have advantages compared with PDT in terms of efficiency in tumor visualization and induction of DAMPs. ABSTRACT: Near-infrared photoimmunotherapy (NIR-PIT) is a new phototherapy that utilizes a monoclonal antibody (mAb) against cancer antigens and a phthalocyanine dye, IRDye700DX (IR700) conjugate (mAb-IR700). Photodynamic therapy (PDT) is a combination therapy that utilizes photoreactive agents and light irradiation as well as NIR-PIT. In the present study, we compared these therapies in vitro. The characterization of cellular binding/uptake specificity and cytotoxicity were examined using two mAb-IR700 forms and a conventional PDT agent, talaporfin sodium, in three cell lines. As designed, mAb-IR700 had high molecular selectivity and visualized target molecule-positive cells at the lowest concentration examined. NIR-PIT induced necrosis and damage-associated molecular patterns (DAMPs), a surrogate maker of immunogenic cell death. In contrast, talaporfin sodium was taken up by cells regardless of cell type, and its uptake was enhanced in a concentration-dependent manner. PDT induced cell death, with the pattern of cell death shifting from apoptosis to necrosis depending on the concentration of the photosensitizer. Induction of DAMPs was observed at the highest concentration, but their sensitivity differed among cell lines. Overall, our data suggest that molecule-specific NIR-PIT may have potential advantages compared with PDT in terms of the efficiency of tumor visualization and induction of DAMPs. MDPI 2023-06-28 /pmc/articles/PMC10340659/ /pubmed/37444510 http://dx.doi.org/10.3390/cancers15133400 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yamashita, Susumu
Kojima, Miho
Onda, Nobuhiko
Shibutani, Makoto
In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
title In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
title_full In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
title_fullStr In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
title_full_unstemmed In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
title_short In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
title_sort in vitro comparative study of near-infrared photoimmunotherapy and photodynamic therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340659/
https://www.ncbi.nlm.nih.gov/pubmed/37444510
http://dx.doi.org/10.3390/cancers15133400
work_keys_str_mv AT yamashitasusumu invitrocomparativestudyofnearinfraredphotoimmunotherapyandphotodynamictherapy
AT kojimamiho invitrocomparativestudyofnearinfraredphotoimmunotherapyandphotodynamictherapy
AT ondanobuhiko invitrocomparativestudyofnearinfraredphotoimmunotherapyandphotodynamictherapy
AT shibutanimakoto invitrocomparativestudyofnearinfraredphotoimmunotherapyandphotodynamictherapy